Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness

Auranofin is an oral gold(I) compound, initially developed for the treatment of rheumatoid arthritis. Currently, Auranofin is under investigation for oncological application within a drug repurposing plan due to the relevant antineoplastic activity observed both in vitro and in vivo tumor models. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamberi, Tania, Chiappetta, Giovanni, Fiaschi, Tania, Modesti, Alessandra, Sorbi, Flavia, Magherini, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299597/
https://www.ncbi.nlm.nih.gov/pubmed/34850406
http://dx.doi.org/10.1002/med.21872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299597/
https://www.ncbi.nlm.nih.gov/pubmed/34850406
http://dx.doi.org/10.1002/med.21872

Ejemplares similares